Based at the Campus Energypolis in Sion and originating from HES-SO Valais, the startup Notrixx continues to develop its technology for detecting bacterial contamination in pharmaceutical products.

The company addresses a critical issue for pharmaceutical and biotechnology manufacturers: the reliable quantification of potentially harmful bacterial contamination in drug products.

An earlier milestone was reached in 2025, when Notrixx received the Best Early-Stage Start-up Award in Zurich. More information about this recognition is available here.

Today, the focus has shifted toward technological validation and market readiness.

Overcoming limitations of existing testing methods

According to founder Anika Hoffmann, current testing approaches often face challenges either in precise quantification or in detection sensitivity.

To address these limitations, Notrixx has developed a method based on the use of a specific biomarker that can be isolated and quantified. This approach is designed to provide a more reliable analytical framework for pharmaceutical manufacturers.

The technology is being developed in close collaboration with HES-SO Valais-Wallis.

Commercial validation underway

In addition to technological development, the startup has initiated exchanges with potential industry partners. Sample testing with prospective clients is currently underway, representing an important step in validating the solution under real-world conditions.

Such validation is essential in a highly regulated sector where analytical performance and reproducibility are key.

2026 priorities: sensitivity and intellectual property

Reaching the sensitivity required for entry into the pharmaceutical market is the primary technical objective for 2026.

At the same time, Notrixx is working to formalize intellectual property arrangements with HES-SO Valais-Wallis and to secure short- and mid-term financing to support further development.

While the company is currently focused on pharmaceutical applications, other potential areas – including nutrition – may be explored in the longer term.